Advertisement
CORT vs CPK
Which Stock Would AI Choose? Corcept Therapeutics (CORT) vs. Chesapeake Utilities (CPK) Stock Comparison
Key Takeaways
- CORT (Corcept Therapeutics) has delivered exceptional year-to-date returns of approximately 160%, driven by strong revenue growth in its biopharmaceutical operations focused on cortisol modulators.
- CPK (Chesapeake Utilities) offers more stable performance with year-to-date returns around 8%, supported by consistent regulated energy operations and a dividend yield of about 2.21%.
- The two stocks represent contrasting sectors: biotechnology with high volatility and growth potential versus regulated utilities emphasizing stability and income.
- CORT trades at a significantly higher valuation multiple (trailing P/E of 258.63) compared to CPK (trailing P/E of 21.43), reflecting differing risk profiles and growth expectations.
- Recent market activity shows CORT benefiting from positive analyst sentiment and pipeline developments, while CPK maintains steady positioning in the energy delivery space.
- Relative performance highlights trade-offs between aggressive growth in healthcare and defensive characteristics in utilities amid current market conditions.
Introduction
This comparison examines CORT and CPK to provide traders and investors with insights into their relative positioning in the current market environment. CORT represents a growth-oriented biotechnology company, while CPK operates as a regulated utility with emphasis on energy delivery. The analysis is relevant for investors seeking to understand sector-specific dynamics, momentum differences, and risk-return trade-offs between high-growth healthcare names and stable income-generating utilities. It supports informed evaluation of market positioning without favoring either security.
CORT Overview and Recent Performance
Corcept Therapeutics Incorporated is a biopharmaceutical company focused on the discovery and development of medications for severe endocrinologic, oncologic, metabolic, and neurologic disorders. Its primary product, Korlym, treats hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome. Recent market activity has shown strong upward momentum, with the stock achieving substantial year-to-date gains amid positive developments in its selective cortisol modulator pipeline. Factors influencing sentiment include analyst upgrades and ongoing clinical progress, contributing to elevated trading volumes and price appreciation over recent weeks. The company maintains a market capitalization of approximately 9.72 billion USD, with performance reflecting broader investor interest in innovative healthcare solutions.
CPK Overview and Recent Performance
Chesapeake Utilities Corporation operates as an energy delivery company through regulated and unregulated segments, including natural gas distribution, transmission, and electric services across multiple states. It also engages in propane operations and sustainable energy solutions. Recent market activity has reflected steady, moderate performance consistent with its defensive utility profile, with year-to-date returns tracking closely to broader market benchmarks. Sentiment has been supported by reliable earnings from regulated operations and a consistent dividend policy. The stock trades with a market capitalization of approximately 3.20 billion USD, demonstrating resilience amid fluctuating energy markets and interest rate environments over recent weeks.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of high-performing AI trading bots from a platform that offers hundreds of AI Trading Bots capable of trading thousands of different tickers. Only the best and most suitable bots for prevailing market conditions earn placement in this section, based on rigorous performance metrics across varied strategies, timeframes, and ticker sets. Available bots exhibit a wide range of statistics, including varying win rates, profit factors, and drawdown profiles, allowing users to explore diverse trading styles from short-term momentum approaches to longer-term trend-following systems. This selection highlights bots demonstrating consistent results in current conditions. For more details on these tools, visit Trending AI Robots.
Head-to-Head Comparison
In terms of business model, CORT focuses on innovative drug development with high research and development intensity, while CPK emphasizes regulated infrastructure and service delivery with predictable cash flows. Growth drivers differ markedly: CORT relies on clinical catalysts and product approvals in biotechnology, whereas CPK benefits from rate base expansion and energy demand stability. Recent momentum favors CORT with outsized returns, contrasted by CPK’s more measured appreciation. Risk factors include binary clinical outcomes and regulatory hurdles for CORT, versus interest rate sensitivity and commodity price exposure for CPK. Sector exposure places CORT in healthcare/biotechnology and CPK in utilities, leading to divergent market sentiment influenced by macroeconomic factors and sector rotation trends.
Tickeron AI Verdict
Based on observable factors such as trend consistency, earnings stability, and relative positioning in recent market activity, Tickeron’s AI would currently assign a probabilistic preference toward CORT for investors with higher risk tolerance seeking growth momentum, while noting CPK’s appeal in defensive scenarios due to its lower volatility and dividend characteristics. This assessment draws from comparative performance metrics and sector dynamics without implying certainty in future outcomes.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CORT is a Buy and CPK is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CORT’s FA Score shows that 1 FA rating(s) are green whileCPK’s FA Score has 0 green FA rating(s).
- CORT’s FA Score: 1 green, 4 red.
- CPK’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CORT’s TA Score shows that 4 TA indicator(s) are bullish while CPK’s TA Score has 6 bullish TA indicator(s).
- CORT’s TA Score: 4 bullish, 4 bearish.
- CPK’s TA Score: 6 bullish, 4 bearish.
Price Growth
CORT (@Biotechnology) experienced а +5.35% price change this week, while CPK (@Gas Distributors) price change was +1.87% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -4.78%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +1901.89%.
The average weekly price growth across all stocks in the @Gas Distributors industry was -0.16%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was +5.21%.
Reported Earning Dates
CORT is expected to report earnings on Aug 05, 2026.
CPK is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Biotechnology (-4.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Gas Distributors (-0.16% weekly)Gas distributors are involved in moving and selling gas – from wellheads or over-distribution systems operated by other firms – to residential and non-residential customers. These companies perform tasks such as the gathering and processing of gas, intrastate and interstate transport, and delivery to the customer. Some of the biggest gas distributing companies in the U.S. include Sempra Energy, Avangrid Inc and Atmos Energy Corporation.
| CORT | CPK | CORT / CPK | |
| Capitalization | 10.2B | 3.26B | 313% |
| EBITDA | -6.19M | 384M | -2% |
| Gain YTD | 174.023 | 10.061 | 1,730% |
| P/E Ratio | 272.46 | 21.79 | 1,250% |
| Revenue | 769M | 984M | 78% |
| Total Cash | 338M | N/A | - |
| Total Debt | 9.64M | 1.67B | 1% |
CORT | CPK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 94 | 89 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 53 | 72 | |
SMR RATING 1..100 | 80 | 73 | |
PRICE GROWTH RATING 1..100 | 35 | 45 | |
P/E GROWTH RATING 1..100 | 5 | 52 | |
SEASONALITY SCORE 1..100 | 90 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CPK's Valuation (74) in the Gas Distributors industry is in the same range as CORT (100) in the Pharmaceuticals Other industry. This means that CPK’s stock grew similarly to CORT’s over the last 12 months.
CORT's Profit vs Risk Rating (53) in the Pharmaceuticals Other industry is in the same range as CPK (72) in the Gas Distributors industry. This means that CORT’s stock grew similarly to CPK’s over the last 12 months.
CPK's SMR Rating (73) in the Gas Distributors industry is in the same range as CORT (80) in the Pharmaceuticals Other industry. This means that CPK’s stock grew similarly to CORT’s over the last 12 months.
CORT's Price Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as CPK (45) in the Gas Distributors industry. This means that CORT’s stock grew similarly to CPK’s over the last 12 months.
CORT's P/E Growth Rating (5) in the Pharmaceuticals Other industry is somewhat better than the same rating for CPK (52) in the Gas Distributors industry. This means that CORT’s stock grew somewhat faster than CPK’s over the last 12 months.
| CORT | CPK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 69% | 2 days ago 68% |
| Stochastic ODDS (%) | 2 days ago 73% | 2 days ago 62% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 58% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 53% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 51% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 46% |
| Advances ODDS (%) | 5 days ago 83% | 13 days ago 48% |
| Declines ODDS (%) | 13 days ago 65% | 5 days ago 52% |
| BollingerBands ODDS (%) | N/A | 2 days ago 61% |
| Aroon ODDS (%) | 2 days ago 74% | 2 days ago 42% |
Advertisement
CORT and
Correlation & Price change
A.I.dvisor indicates that over the last year, CORT has been loosely correlated with VTVT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then VTVT could also see price increases.
| Ticker / NAME | Correlation To CORT | 1D Price Change % | ||
|---|---|---|---|---|
| CORT | 100% | -1.34% | ||
| VTVT - CORT | 49% Loosely correlated | -2.94% | ||
| TENX - CORT | 41% Loosely correlated | -0.75% | ||
| AGIO - CORT | 41% Loosely correlated | +0.22% | ||
| ARCT - CORT | 37% Loosely correlated | -4.49% | ||
| AXON - CORT | 36% Loosely correlated | +2.12% | ||
More | ||||
CPK and
Correlation & Price change
A.I.dvisor indicates that over the last year, CPK has been closely correlated with OGS. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CPK jumps, then OGS could also see price increases.